MEZOO Co., Ltd.

Mezoo was established in 2018 in Wonju, Korea. The company is led by four founders, all with backgrounds in biomedical engineering, bringing strong technical expertise to the development of medical devices and digital health solutions.

Mezoo is one of the first companies in Korea to introduce ambulatory remote patient monitoring (aRPM), enabling continuous patient monitoring beyond the hospital environment.

Mezoo has developed HiCardi+, a wearable ECG-based remote patient monitoring system designed to support real-time cardiac monitoring and proactive patient management.

HiCardi+ is built around a lightweight (18g) wearable smart patch, which is rechargeable and can be used for up to 72 hours on a single charge. The device is designed for ease of use in both clinical and home settings, with IP67-rated durability for daily life conditions.

The solution has obtained regulatory approvals in nine countries, including CE marking in Europe, demonstrating compliance with international medical device standards.

Mezoo aims to improve patient outcomes by enabling earlier detection of cardiac abnormalities and reducing the risk of critical events through continuous monitoring.